Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CANCOM SE Earnings Release 2013

Mar 19, 2014

71_rns_2014-03-19_411aa6f6-c3af-49cc-8582-f7306679d83d.pdf

Earnings Release

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

CANCOM

(TecDAX, Software/IT)

Buy Last Rating Share data:
Bloomberg:
COK GR FY End: 31.12.
in EUR m
CAGR
(12-15e)
2012 2013e 2014e 2015e
EUR 42.00 Last PT Reuters:
ISIN:
COKG
DE0005419105
Sales
EBIT
Net income
12.5 %
30.6 %
39.5 %
558.1
20.7
11.5
613.4
24.4
16.4
760.7
32.5
21.7
795.0
46.0
31.1
Market Snapshot:
Market cap:
EUR m
534.9
EPS
DPS
25.0 %
0.0 %
1.09
0.35
1.39
0.35
1.48
0.35
2.13
0.35
Price EUR 36.60 No. of shares (m): 14.6 EV / Sales
EV / EBIT
0.2 x
4.7 x
0.7 x
18.2 x
0.6 x
14.7 x
0.6 x
9.7 x
Upside 14.8 % EV:
Freefloat MC:
Ø Trad. Vol. (30d; EUR):
478.2
513.5
4.22 m
P / E 11.0 x 26.3 x 24.7 x 17.2 x

Final figures confirm preliminaries; Acquisition of DIDAS

CANCOM has released final figures confirming preliminary published sales and EBITDA figures.

CANCOM - Q4 2013
Figures in EUR m Q4/13 Q4/13e Q4/12 yoy 2013 2013e 2012 yoy
Sales 196.3 195.9 151.3 29.8% 613.8 613.4 558.1 10.0%
Gross profit
margin
52.9
27.0%
56.6
28.9%
42.9
28.3%
23.5% 186.5
30.4%
190.2
31.0%
165.5
29.7%
12.7%
EBITDA
margin
10.6
5.4%
10.5
5.4%
7.8
5.2%
35.1% 33.4
5.4%
33.3
5.4%
28.1
5.0%
19.0%
EPS in EUR 0.27 0.39 0.32 -15.6% 1.23 1.39 1.09 12.8%

Sources: CANCOM (historical data), Warburg Research (estimates)

  • 2013 organic growth was 6.7%. The increasing service business had a positive impact on the gross margin which rose by 0.6 percentage points to 30.4%. The improvement in the EBITDA margin also reflects a higher share of cloud service revenues.
  • EPS fell short of our expectations as depreciation and amortisation from recent acquisitions had a stronger than anticipated negative impact on the bottom line.
  • By the end of 2013, cash equivalents amounted to EUR 77.7m
  • As a result of the strong EBITDA growth in 2013, the dividend proposal will be raised to EUR 0.40 per share (from EUR 0.35 last year). This increase underpins the continuation of a strong operative development: January and February were above previous year's level.
  • Along with the figures, CANCOM announced the planned acquisition of DIDAS. The services company which also addresses the cloud business will be purchased from the listed peer Allgeier. In 2013, DIDAS generated revenues of EUR 56m and an EBITDA of EUR 1.8m. According to an Allgeier release, the price is in line with current market multiples. We assume that with this acquisition CANCOM aims to gain access to potential AHP Private Cloud customers that come with EBITDA margins of c. 40%.
  • Given the recent acquisitions, most recently DIDAS Business Services GmbH, as announced yesterday, management expects "gross profit and EBITDA for the Group to increase substantially" in 2014.
  • A web conference is scheduled for 3 p.m. CET. Comment will follow

LEGAL DISCLAIMER

This research report was prepared by the Warburg Research GmbH, a subsidiary of the M.M.Warburg & CO KGaA and is passed on by the M.M.Warburg & CO KGaA. It contains selected information and does not purport to be complete. The report is based on publicly available information and data ("the information") believed to be accurate and complete. Warburg Research GmbH neither does examine the information to be accurate and complete, nor guarantees its accuracy and completeness. Possible errors or incompleteness of the information do not constitute grounds for liability of M.M.Warburg & CO KGaA or Warburg Research GmbH for damages of any kind whatsoever, and M.M.Warburg & CO KGaA and Warburg Research GmbH are not liable for indirect and/or direct and/or consequential damages. In particular, neither M.M.Warburg & CO KGaA nor Warburg Research GmbH are liable for the statements, plans or other details contained in these analyses concerning the examined companies, their affiliated companies, strategies, economic situations, market and competitive situations, regulatory environment, etc. Although due care has been taken in compiling this research report, it cannot be excluded that it is incomplete or contains errors. M.M.Warburg & CO KGaA and Warburg Research GmbH, their shareholders and employees are not liable for the accuracy and completeness of the statements, estimations and the conclusions derived from the information contained in this document. Provided a research report is being transmitted in connection with an existing contractual relationship, i.e. financial advisory or similar services, the liability of M.M.Warburg & CO KGaA and Warburg Research GmbH shall be restricted to gross negligence and wilful misconduct. In case of failure in essential tasks, M.M.Warburg & CO KGaA and Warburg Research GmbH are liable for normal negligence. In any case, the liability of M.M.Warburg & CO KGaA and Warburg Research GmbH is limited to typical, expectable damages. This research report does not constitute an offer or a solicitation of an offer for the purchase or sale of any security. Partners, directors or employees of M.M.Warburg & CO KGaA, Warburg Research GmbH or affiliated companies may serve in a position of responsibility, i.e. on the board of directors of companies mentioned in the report. Opinions expressed in this report are subject to change without notice. All rights reserved.

COPYRIGHT NOTICE

This work including all its parts is protected by copyright. Any use beyond the limits provided by copyright law without permission is prohibited and punishable. This applies, in particular, to reproductions, translations, microfilming, and storage and processing on electronic media of the entire content or parts thereof.

DISCLOSURE ACCORDING TO §34B (1) OF THE GERMAN SECURITIES TRADING ACT (WHPG) AND THE ORDINANCE ON THE ANALYSIS OF FINANCIAL INSTRUMENTS (FINANV)

The valuation underlying the investment recommendation for the company analysed here is based on generally accepted and widely used methods of fundamental analysis, such as e.g. DCF Model, Free Cash Flow Potential, Peer Group Comparison or Sum of the Parts Model. The result of this fundamental valuation is modified to take into consideration the analyst's assessment as regards the expected development of investor sentiment and its impact on the share price.

Independent of the applied valuation methods, there is the risk that the price target will not be met, for instance because of unforeseen changes in demand for the company's products, changes in management, technology, economic development, interest rate development, operating and/or material costs, competitive pressure, supervisory law, exchange rate, tax rate etc. For investments in foreign markets and instruments there are further risks, generally based on exchange rate changes or changes in political and social conditions.

This commentary reflects the opinion of the relevant author at the point in time of its compilation. A change in the fundamental factors underlying the valuation can mean that the valuation is subsequently no longer accurate. Whether, or in what time frame, an update of this commentary follows is not determined in advance.

In accordance with § 5 (4) of the Ordinance on the Analysis of Financial Instruments (FinAnV) Warburg Research GmbH has implemented additional internal and organisational arrangements to prevent or to deal with conflicts of interest. Among these are the spatial separation of Warburg Research GmbH from M.M.Warburg & CO KGaA and the creation of areas of confidentiality. This prevents the exchange of information, which could form the basis of conflicts of interest for Warburg Research in terms of the analysed issuers or their financial instruments.

The analysts of Warburg Research GmbH do not receive a gratuity – directly or indirectly – from the investment banking activities of M.M.Warburg & CO KGaA or of any company within the Warburg Group.

All prices of financial instruments given in this financial analysis are the closing prices on the last stock-market trading day before the publication date stated, unless another point in time is explicitly stated.

M.M.Warburg & CO KGaA and Warburg Research GmbH are subject to the supervision of the Federal Financial Supervisory Authority, BaFin.

SOURCES

All data and consensus estimates have been obtained from FactSet except where stated otherwise.

Section 34b of the German Securities Trading Act in combination with the FinAnV requires an enterprise preparing a securities analysis to point out possible conflicts of interest with respect to the company that is the subject of the analysis. A conflict of interest is assumed, in particular, when the enterprise preparing the analysis …

-1- … or companies affiliated with this enterprise holds 5% or more of the share capital of the analysed company
-2- … or companies affiliated with this enterprise were involved in the management of a consortium for a public offering of
securities which are or whose issuer is the subject of this report within the last twelve months
-3- … or companies affiliated with this enterprise manages the securities of the analysed company on the basis of an existing
contract
-4- … or companies affiliated with this enterprise over the previous 12 months has been providing investment banking services
for the analysed company for which a compensation has been or will be paid. Warburg Research GmbH receives indirect
remuneration from the investment banking activities of M.M.Warburg & CO KGaA.
-5- … effected an agreement with the analysed company for the preparation of the financial analysis
-6- … or companies affiliated with this enterprise regularly trade in shares or derivatives of the analysed company
-7- … or the analyst responsible for this company has other important financial interests in relation to the analysed company
such as e.g. the performance of mandates for the analysed company
Company Disclosure Link to the historical price targets and rating changes (last 12 months)
CANCOM 5, 6 http://www.mmwarburg.com/disclaimer/disclaimer_en/DE0005419105.htm

INVESTMENT RECOMMENDATION

Investment recommendation: expected direction of the share price development of the financial instrument up to the given price target in the opinion of the analyst who covers this financial instrument.

-B- Buy: The price of the analysed financial instrument is expected to rise over the next 12 months.
-H- Hold: The price of the analysed financial instrument is expected to remain mostly flat over the next 12
months.
-S- Sell: The price of the analysed financial instrument is expected to fall over the next 12 months.
"-" Rating suspended: The available information currently does not permit an evaluation of the company.

WARBURG RESEARCH GMBH – RESEARCH UNIVERSE BY RATING

Rating Number of stocks % of Universe
Buy 91 46
Hold 90 45
Sell 16 8
Rating suspended 3 2
Total 200 100

WARBURG RESEARCH GMBH – ANALYSED RESEARCH UNIVERSE BY RATING …

… Looking only at companies for which a disclosure according to § 34b of the Germany Securities Trading Act and the FinAnV has to be made.

Rating Number of stocks % of Universe
Buy 74 50
Hold 64 44
Sell 7 5
Rating suspended 2 1
Total 147 100

PRICE AND RATING HISTORY CANCOM AS OF 19.03.2014

The chart has markings if Warburg Research GmbH changed its rating in the last 12 months. Every marking represents the date and closing price on the day of the rating change.

CANCOM

RESEARCH

Head of Equity Sales, USA [email protected] Head of Sales Trading [email protected]

Klaus Schilling +49 40 3282-2664 Gudrun Bolsen +49 40 3282-2679 Dep. Head of Equity Sales, GER [email protected] Sales Trading [email protected]

Marie-Therese Grübner +49 40 3282-2630 Jörg Treptow +49 40 3262-2658 France [email protected] Sales Trading [email protected]

Dirk Rosenfelder +49 40 3282-2692 Austria, Switzerland [email protected]

Australia, United Kingdom [email protected]

Software, IT [email protected] Utilities [email protected]

Ulrich Huwald +49 40 309537-255 Oliver Schwarz +49 40 309537-250 Health Care, Pharma [email protected] Chemicals, Agriculture [email protected]

Retail, Consumer Goods [email protected] Automobiles, Car Suppliers [email protected]

Real Estate [email protected] Steel, Car Suppliers [email protected]

Tim Beckmann +49 40 3282-2665 Bastian Quast +49 40 3282-2701

Matthias Fritsch +49 40 3282-2696 Thekla Struve +49 40 3282-2668

Ömer Güven +49 40 3282-2633 Jan Walter +49 40 3262-2689 Germany [email protected] Sales Trading [email protected]

Michael Kriszun +49 40 3282-2695 Katharina Merckel +49 40 3282-2694 United Kingdom [email protected] Roadshow/Marketing [email protected]

Marc Niemann +49 40 3282-2660 Germany [email protected]

Philipp Stumpfegger +49 40 3282-2635

SALES SALES TRADING

MACRO RESEARCH

Roland Rapelius +49 40 309537-220 Andreas Pläsier +49 40 309537-246 Head of Research [email protected] Banks, Financial Services [email protected]

Henner Rüschmeier +49 40 309537-270 Malte Räther +49 40 309537-185 Head of Research hrueschmeier @warburg-research.com Technology, Telco, Internet [email protected]

Christian Cohrs +49 40 309537-175 Jochen Reichert +49 40 309537-130 Engineering, Logistics [email protected] Telco, Internet, Media [email protected]

Felix Ellmann +49 40 309537-120 Christopher Rodler +49 40 309537-290

Jörg Philipp Frey +49 40 309537-258 Malte Schaumann +49 40 309537-170 Retail, Consumer Goods [email protected] Technology [email protected]

Harald Hof +49 40 309537-125 Susanne Schwartze +49 40 309537-155 Medtech [email protected] Telco, Internet, Media [email protected]

Thilo Kleibauer +49 40 309537-257 Marc-René Tonn +49 40 309537-259

Torsten Klingner +49 40 309537-260 Björn Voss +49 40 309537-254

Eggert Kuls +49 40 309537-256 Andreas Wolf +49 40 309537-140 Engineering [email protected] Software, IT [email protected]

Frank Laser +49 40 309537-235 Stephan Wulf +49 40 309537-150 Construction, Industrials [email protected] Utilities [email protected]

Holger Nass +49 40 3282-2669 Oliver Merckel +49 40 3282-2634

Christian Alisch +49 40 3282-2667 Michael Ilgenstein +49 40 3282-2700 Scandinavia, Spain [email protected] Sales Trading [email protected]

United Kingdom [email protected] Sales Trading [email protected]

United Kingdom [email protected] Sales Trading [email protected]

Carsten Klude +49 40 3282-2572 Macro Research [email protected]

Matthias Thiel +49 40 3282-2401 Macro Research [email protected]

Dr. Christian Jasperneite +49 40 3282-2439 Investment Strategy [email protected]

Our research can be found under:

Warburg Research research.mmwarburg.com/en/index.html Thomson www.thomson.com
Bloomberg MMWA GO Reuters www.knowledge.reuters.com
FactSet www.factset.com Capital IQ www.capitaliq.com
For access please contact:
Andrea Schaper
Sales Assistance
+49 40 3282-2632
[email protected]
Kerstin Muthig
Sales Assistance
+49 40 3282-2703
[email protected]